Fundraising Fox
Avenzo
San Diego, US · Founded 2022 · 13 known investors
Find your way into Avenzo
Sign up to see every warm intro you have to Avenzo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avenzo team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments. The company focuses on oncology and cell therapy programs.
Founders & leadership
Avenzo was founded in 2022 by Athena Countouriotis and Mohammad Hirmand.
Board
Investors · 13
How we know: press coverage · Not right? Tell us
How we know: Foresite Capital's portfolio page · press coverage · Not right? Tell us
How we know: INCE Capital's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
How we know: Longwood Fund's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · funding news · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: SR One Capital Management's portfolio page · funding news · press coverage · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$433.1M disclosed across 2 rounds · 2022–2025
▶$47.2MraisedSep 2025 · 20 investors · BiotechnologyRule 506(b)
- Carl GordonDirector
- Garry NicholsonDirector
- Patrick MachadoDirector
- Judith LiDirector
- Paolo TombesiExecutive Officer
- Mohammad HirmandExecutive Officer
- Simeon GeorgeDirector
- Scott LipmanExecutive Officer
- Athena CountouriotisExecutive Officer, Director
- Brian SunExecutive Officer
- Jakob Dupont, M.D., M.A.Director
- Offering amount
- $75M
- Amount sold
- $47.2M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$385.9MraisedNov 2024 · 22 investors · BiotechnologyRule 506(b)
- Athena CountouriotisExecutive Officer, Director
- Carl GordonDirector
- Judith LiDirector
- Scott LipmanExecutive Officer
- Mohammad HirmandExecutive Officer
- Jakob Dupont, M.D., M.A.Director
- Garry NicholsonDirector
- Brian SunExecutive Officer
- Paolo TombesiExecutive Officer
- Simeon GeorgeDirector
- Offering amount
- $385.9M
- Amount sold
- $385.9M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Avenzo.
In the news
Frequently asked questions
- What does Avenzo do?
- Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments. The company focuses on oncology and cell therapy programs.
- Who founded Avenzo?
- Avenzo was founded by Athena Countouriotis, Mohammad Hirmand in 2022.
- Who are Avenzo's investors?
- Avenzo's investors include Delos Capital, Foresite Capital, INCE Capital, Longwood Fund, New Enterprise Associates (NEA), OrbiMed, Quan Capital, Sofinnova Ventures and 5 more.
- How much funding has Avenzo raised?
- Avenzo has disclosed $433.1M raised across 2 rounds.
- Where is Avenzo headquartered?
- Avenzo is headquartered in San Diego, US.